Secondary Chemoprevention of Barrett’s Esophagus With Celecoxib: Results of a Randomized Trial

BACKGROUND: Barrett’s esophagus is a premalignant condition that is a risk factor for the development of esophageal adenocarcinoma, a disease whose incidence is rapidly increasing. Because aspirin and other nonsteroidal antiinflammatory drugs, such as celecoxib, may decrease the risk of developing e...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Heath, Elisabeth I., Canto, Marcia Irene, Piantadosi, Steven, Montgomery, Elizabeth, Weinstein, Wilfred M., Herman, James G., Dannenberg, Andrew J., Yang, Vincent W., Shar, Albert O., Hawk, Ernest, Forastiere, Arlene A.
Formato: Artigo
Idioma:Inglês
Publicado: 2007
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755596/
https://ncbi.nlm.nih.gov/pubmed/17405999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djk112
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares